Brind.

Chemed Corporation, headquartered in Cincinnati, operates Roto-Rooter and VITAS Healthcare as wholly owned subsidiaries.

13 reports, 8 independent Updated Sep 22
Mostly repetition Reached 5 outlets in its first 24 hours
Reports
13
Developments
4
Repetition
85%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 8 independent outlets

Chemed Corporation, headquartered in Cincinnati, operates Roto-Rooter and VITAS Healthcare as wholly owned subsidiaries.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Chemed expanded Roto-Rooter operations into Sacramento and Fresno after acquiring a major franchise.1 source
  2. Kevin McNamara became CEO of Chemed, and Vitas received acquisition support from Covington Health.Sub-event
  3. Vitas hospice business issues caused a stock plunge on July 1, 2025.Sub-event
  4. Chemed Corporation is headquartered in Cincinnati and owns Roto-Rooter and VITAS Healthcare.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • insidermonkey.com
  • fool.com
  • manilatimes.net
  • Business WireChemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents CINCINNATI, August 01, 2025--(BUSINESS WIRE)--Chemed Corpo
  • GlobeNewswireVITAS® Healthcare Announces CEO Transition and Appointment of New Chief Executive Officer MIRAMAR, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- VITAS Healthcare, one of the nation’s leading providers of h
  • Business WireChemed Reports Second-Quarter 2025 Results and Announces Executive Management Departure CINCINNATI, July 29, 2025--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healt
  • StockStoryChemed’s (NYSE:CHE) Q2 Earnings Results: Revenue In Line With Expectations But Stock Drops Healthcare services company Chemed Corporation (NYSE:CHE) met Wall Street’s revenue expectations in Q2 CY202
  • ZacksChemed (CHE) Q2 Earnings Miss Estimates Chemed (CHE) came out with quarterly earnings of $4.27 per share, missing the Zacks Consensus Estimate of $4.78 per share. This compares to earnings of $5.47 p
  • Insider MonkeyChemed Corporation (CHE): A Bull Case Theory We came across a bullish thesis on Chemed Corporation on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ thesis on CH
  • ZacksAnalysts Estimate Chemed (CHE) to Report a Decline in Earnings: What to Look Out for Wall Street expects a year-over-year decline in earnings on higher revenues when Chemed (CHE) reports results for
  • Unknown outlet
2 more outlets ran the same wire story